Americans are drinking less alcohol as they get older, and many are switching from beer and hard liquor to wine, a new report says.

Researchers at Boston University School of Medicine studied 8,600 white adults in Framingham, MA, over 50 years. The participants, born between 1900 to 1959, joined the study when they were at least 28 years old and answered questions about their lifestyle and health, including their alcohol use for the past few decades

A U.S. panel that studies the effectiveness of clinical preventive services and medications has recommended that men aged 75 and above avoid prostate cancer screening because it offers few benefits and more harm.

According to the recommendation of the U.S. Preventive Services Task Force appearing in Tuesday's issue of the Annals of Internal Medicine, the panel found evidence that prostate cancers detected through the prostate-specific antigen (PSA) test take more than 10 years, the life expectancy of men over 75, to become life-threatening

For the first time, Britain has allowed an oral antibiotic used to treat chlamydia to be sold without prescription, the Medicines and Healthcare Products Regulatory Agency (MHRA) said on Wednesday.

People over 16 will be able to buy the azithromycin pill Clamelle, manufactured by Icelandic drugmaker Actavis, after testing positive for the infection. The drug will also be made available over-the-counter (OTC) for their sexual partners. The new regulation will come into effect later this year

Despite being banned by the federal health agency, there has been a continued use of over-the-counter (OTC) cough and cold medications in children, new studies have shown.

There has been a sudden rise in the number of small children taken to the emergency room after they stop breathing or lose consciousness from consuming over-the-counter cold medications in their systems, two studies appearing in the August issue of Pediatrics say

An independent panel of experts Monday recommended against prostate cancer screenings for men older than 74 due to more evidence of harm than benefit.

The U.S. Preventive Services Task Force (USPSTF), updating its 2002 report, added that more evidence is needed to determine if men under 75 could benefit from screening